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Background: Several studies have demonstrated a fundamental role for the HLA in the susceptibility of, or
protection to, type 1 diabetes mellitus (T1DM). However, this has not been adequately studied in Asian Indian
populations. To assess the frequency of HLA class II (DPA1, DPB1, DQA1, DQB1 and DRB1) associated to
susceptibility or protection toT1DM in a Bengali population of India with diabetes.
Results: Single nucleotide polymorphism study. The HLA genotyping was performed by a polymerase chain
reaction followed by their HLA-DP, DQ, and DRB1 genotypes and haplotypes by sequencing method. The results
are studied by Plink software. The χ2 tests were used for the inferential statistics. To our knowledge, this study is the
first of a kind which has attempted to check the HLA association with T1DM by SNPs analysis. The study recruited
151 patients with T1DM and same number of ethno-linguistic, sex matched non-diabetic controls. The present
study found a significant SNP rs7990 of HLA-DQA1 (p = 0.009) negative correlation, again indicating that risk from
HLA is considerably more with T1DM.
Conclusions: This study demonstrates that the HLA class-II alleles play a major role in genetic basis of T1DM.
Keywords: HLA, T1DM, SNP, India, Haplotyping, AllelesBackground
Type 1 diabetes mellitus (T1DM) (OMIM-222100),
results from a cellular-mediated autoimmune destruc-
tion of the Beta-cell of the pancreas [1]. T1DM is a dis-
ease of major public health concern [2-4]. The previous
studies showed that in India, the prevalence of T1DM
varies from about 1.6 to 10.5/100000/year [5,6]. The epi-
demiological study conducted in South Indian popula-
tion for four years, suggested the prevalence of T1DM in
India is increasing. The overall prevalence of T1DM in
Karnal district, a North Indian city with a population of
222017, is 10.20/100,000 population [7].
The genetic risk factors of T1DM are better under-
stood than the environmental risk factors. Studies on
Human and animal models show the MHC class II–* Correspondence: ansidiabetes@gmail.com
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reproduction in any medium, provided the ormediated effects on the disease susceptibility [8]. Early
studies identified in the Human Leukocyte Antigen
(HLA) genes, located on chromosome 6p21.31 as T1DM
susceptibility genes. Resulting studies showed an asso-
ciation between the insulin gene on chromosome 11p15.5.
The risk of T1DM is linked with about 18 regions of the
genome. These regions, each of which may contain mul-
tiple genes, labeled IDDM1 to IDDM18. The best studied
is IDDM1, which contains the HLA genes encode proteins
of the immune response [9,10].
HLA is one of the most polymorphic genetic systems
in Human genome. IMGT/HLA database have reported
6,275 HLA alleles [11]. Because the HLA class II
molecules are polymorphic, they can embrace a wide
variety of antigens in their antigen-binding groove and
present them to diverse T-lymphocyte antigen receptors,
triggering antigen recognition. Several studies have
displayed HLA class II alleles, DQ and DR influence
T1DM susceptibility. The contribution of the DQd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Raha et al. Journal of Biomedical Science 2013, 20:12 Page 2 of 6
http://www.jbiomedsci.com/content/20/1/12molecules to overall disease susceptibility might be
genotype dependent and/or may be influenced by the
DRB1*04 allele on the haplotype [12].
The HLA-DQ heterodimers encoded by the
DQA1*0301, DQB1*0302 and DQA1*0501, DQB1*0201
alleles have the strongest association with T1DM [13].
These alleles are in LD with the HLA-DR4 and -DR3
alleles. In T1DM at least one allele of DR3 or DR4 is
found in 95% in Europeans, and individuals with both
DR3 and DR4 are particularly susceptible to T1DM,
whereas, the DR2 allele is protective [14-16].
In North Indian T1DM patients also, the homozygos-
ity and heterozygosity of DRB1*0301 and DRB1*04
alleles is significantly associated [17-19]. The Indian
samples show HLA-C*0702 allele and shared HLA-B
*0801 and DQB1*02 with the European 8.1AH [20-23].
The role of DP molecules has yet to be resolved satis-
factorily. The results favor DPB1*0301 and DPB1*0202
alleles as predisposing for T1DM [24]. Analysis of
family-based data from the Human Biological Data
Interchange (HBDI) repository and Italian studies,
suggests the presence of a T1DM protective locus at or
near DPB1*0101 [25]. It is hypothesized that the
strongest candidates for increasing T1DM risk among
DR3-DQB1*0201/DR4-DQB1*0302 individuals is of alleles
of DP and DRB1*04 subtypes and, in particular, the
absence of reportedly protective alleles DPB1*0402
and/or DRB1*0403 [26].
There are some studies on HLA-DP in different ethnic
groups mainly about HLA-DPB1. In a study from Sudan,
there were no significant differences between Sudanese
patient and control groups in HLA-DPB1 frequencies
[27]. Although, there was also no noticeable associationTable 1 List of primers used in the present study to amplify g
Designation Chromosome location Sequence
HLA-DPA1* 6p21.3 (Exon2) F-5’ GCGGACCATGTGTG
R-5’ GCCTGAGTGTGGTT
HLA-DPB1* 6p21.3 (Exon2) F-5’ GAGAGTGGCGCCTC
R-5’ GCCGGCCCAAAGCC
HLA-DQA1 6p21.3$ (Exon1) F-5’ CAAACTCTTCAGCTA
R-5’ CATGCACTCACCCA
6p21.3* (Exon2) F-5’ ATGGTGTAAACTTGT
R-5’ TTGGTAGCAGCGGT
6p21.3$ (Exon3) F-5’ AGGTTCCTGAGGTC
R-5’ CTTGACAGACAAGA
HLA-DQB1* 6p21.3(Exon2) F-5’ CATGTGCTACTTCAC
R-5’ CTGGTAGTTGTGTCT
HLA-DRB1* 6p21.3(Exon2) F-5’ CCCCACAGCACGTT
R-5’ CCGCTGCACTGTGA
*(Tanaka et al. 1999), $(Cordovado et al. 2005).between T1DM and HLA-DPB1 allele in Japanese [28].
From Indian T1DM patients, so far no studies have been
reported on DP molecules.
Although different methods exist to characterize the
polymorphisms in HLA genes, the 12th International
Histocompatibility Workshop suggested the Sequence
Based Typing (SBT) methods [29]. Therefore, we
conducted a hospital-based case–control study in the
West Bengal region of India to find out the role of




In the present study 151 T1DM patients were recruited
from six different hospitals - Calcutta Heart and Re-
search Clinic; Endocrinology Department, Calcutta Me-
dical College & Hospital; Endocrinology Department,
SSKM Hospital; Netaji Subhash Chandra Bose Cancer
Research Institute; Rabindranath Research Institute of
Cardiac Sciences; School of Tropical Medicine; from
metropolitan Kolkata. The inclusion criteria considered
for recruitment of cases were an onset of diabetes below
39 years of age, and presenting with or without acute
ketosis with absolute insulin dependence, as shown by
a deficient C-peptide secretion i.e., a C-peptide value
less than 0.6 (0.6-3.2)ng/ml and antibody positivity
for Glutamic Acid Decarboxylase antigen(GADA) and,
Insulinoma-Associated Protein-2 Antibodies (/IA-2/ICA512)
[30]. Patients of at least one year duration were selected to
exclude acute or “honeymoon” phases.
The sampled subjects speak Bengali. The samples
represented in our study is mainly originated fromenes
Annealing temperature Product size(bp)
TCAACTTAT 3’ 55°C 210
GGAACG 3’
CGCTCAT 3’ 63°C 327
CTCACTC 3’
GTAAC 3’ 58°C 262
CAAT 3’
ACCAGT 3’ 55°C 229
AGAGTTG 3’
ACAGTGTTT 3’ 54°C 328
AAGCATC 3’
CAACGG 3’ 58°C 211
GCACAC 3’
TCTTG 3’ 60°C 274
AGCTCT 3’
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Parganas, Howrah, Hoogly, comprising a small geo-
graphical area and historically forming a cultural zone.
West Bengal is the melting pot of Indo-Aryan, Austric,
Dravidian, Tibeto-Burman and various other languages
[31]. Some scholar stated that Bengal had many striking
resemblance with the Dravidian culture [32], where as
others suggested that Bengal as the meeting place of
Aryan, non-Aryan, and Mongoloid races [33].
The controls used in the present study represent 151
healthy individuals without T1DM and T2DM in the
family history, and matched for ethnicity, geography and
socioeconomic status and higher age compared to cases.
Blood samples (3 ml) were collected into EDTA-coated
vacutainers from both cases and controls with writtenTable 2 Genotyping of SNPs in LD blocks
Genotype MAF (%) HWE-p value
rs1047993 TT TC CC
Cases 2 (1.45) 26 (18.84) 110 (79.79) 10.9 0.745
Control 2 (1.33) 18 (12.0) 130 (86.67) 7.3 0.152
rs9272699 AA AC CC
Cases 2 (1.42) 15 (10.64) 124 (87.94) 6.7 0.068
Control 0 (0) 15 (10.14) 133 (89.86) 5.1 0.516
rs1048052 CC AC AA
Cases 4 (2.84) 17 (12.06) 120 (85.11) 8.9 0.003
Control 0 (0) 17 (11.49) 131 (88.51) 5.7 0.459
rs36219014 TT CT CC
Cases 0 (0) 17 (12.06) 124 (87.94) 6 0.446
Control 0 (0) 15 (10.27) 131 (89.73) 5.1 0.513
rs707962 GG GT TT
Cases 0 (0) 30 (20.69) 115 (79.31) 10.3 0.165
Control 0 (0) 19 (12.58) 132 (87.42) 6.3 0.409
rs2308911 CC CA AA
Cases 15 (10.95) 66 (48.18) 56 (40.88) 35 0.495
Control 14 (10.37) 61 (45.19) 60 (44.44) 33 0.795
rs2308912 AA AT TT
Cases 14 (10.0) 64 (45.71) 62 (44.29) 32.9 0.669
Control 12 (9.09) 61 (46.21) 59 (44.70) 32.2 0.502
rs707949 CC CT TT
Cases 0 (0) 30 (20.69) 115 (79.31) 10.3 0.165
Control 0 (0) 20 (13.25) 131 (86.75) 6.6 0.384
rs7990 AA AC CC
Cases 0 (0) 14 (9.72) 130 (90.28) 4.9 0.549
Control 0 (0) 31 (20.53) 120 (79.47) 10.3 0.160
rs707963 GG GT TT
Cases 0 (0) 28 (19.31) 117 (80.69) 9.7 0.198
Control 0 (0) 18 (11.92) 133 (88.08) 6 0.436
MAF =Minor Allele Frequency, HWE = Hardy-Weinberg Equilibrium.informed consent. This research was approved by the In-
stitutional Review Board of the Anthropological Survey
of India as well as by the respective hospital’s ethical
committee.
Genotyping
DNA was isolated according to the standard protocol
[34]. Genotyping of the following HLA genes HLA-
DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1, and
HLA-DRB1 was performed using PCR followed by se-
quencing. The primers used in the present study to
amplify different regions of aforementioned genes are
documented in Table 1. A total volume of 10 μl was
used for each PCR reaction which were carried out in
an ABI Gene Amp PCR system 9700. The nucleotideDominant OR (p value) Recessive OR (p value) Allelic OR(p value)
1.65 (0.114) 1.09 (0.933) 1.54 (0.139)
1.22 (0.603) 1.35 (0.394)
1.35 (0.392) 1.60 (0.148)
120 (0.631) 1.18 (0.642)
1.81 (0.061) 1.72 (0.074)
1.16 (0.552) 1.06 (0.877) 1.10 (0.610)
1.02 (0.946) 1.11 (0.799) 1.03 (0.870)
1.71 (0.087) 1.63 (0.104)
0.42 (0.009) 0.45 (0.013)
1.77 (0.079) 1.69 (0.093)
Figure 1 Pair-wise linkage disequilibrium between the ten SNP markers in HLA-DQA1-DPA1 genes.
Table 3 HLA-DQA1 and-DPA1 gene haplotypes and T1DM
rs1047993, rs9272699, rs1048052, rs36219014 and rs707949
Haplotype Control Case χ2 p-value
CCACT 0.883 0.939 5.672 0.017
TACTC 0.060 0.051 0.255 0.614
TCACC 0.028 0.003 5.875 0.015
rs707963 and rs707962
Haplotype Control Case χ2 p-value
TT 0.897 0.937 3.202 0.074
GG 0.097 0.060 2.818 0.093
rs2308911 and rs2308912
Haplotype Control Case χ2 p-value
TA 0.650 0.663 0.107 0.744
AC 0.336 0.307 0.501 0.479
TC 0.015 0.022 0.436 0.509
χ 2=its chi square.
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direct sequencing using di-deoxy chain terminator cycle
sequencing protocol through 3730 DNA Analyzer (BigDye
V3.1, Applied Biosystems; Foster City, CA, USA). Sequen-
cing was carried out with both the forward and the reverse
directions. Problems in genotype assignment for certain
samples on the DRB1 and the DQB1 loci that aroused be-
cause of the genotypic ambiguity were surmounted by
following the guidelines of the American Society for
Histocompatibility and Immunogenetics [35].
Statistical analysis
All nucleotide changes detected by using SeqScape soft-
ware v 2.5 (Applied Biosystems) and with the wild gene
using pair-wise BLAST [36]. Class II HLA genes are
more polymorphic compared to other genes and thus
the editing was much more complicated for Class II
HLA. Allele and genotype frequencies of the SNP data
compared between T1DM patients and healthy control
groups. Statistical analysis for HWE was performed by
Plink v 1.07 software [37]. Evaluation of the genotype or
allele frequencies of cases and controls was carried out
by calculating the odds ratios (OR) with 95% of confi-
dence intervals (CI). A P value less than 0.05 were
considered as statistically significant. Haplotype frequen-
cies and linkage disequilibrium estimated by using
Haploview v 4.1, which measures D’ and r2 between each
pair of SNPs and to define haploblocks [38].
Results and discussions
Exonic 331 SNPs in the Class II HLA- DP-DQ-DRB1,
identified and tested for HWE by Plink software. Onlyten SNPs found to be in equilibrium for control, only
these 10 SNPs were used in further analysis. Of the 10
SNPs, eight were from HLA-DQA1 and the remaining
were from HLA-DPA1 (rs2308911, rs2308912) (Table 2).
Allele and genotype frequencies of all the SNPs for both
cases and controls were presented in Table 2. Except for
rs7990 (p = 0.009), there were no significant differences
in genotype or allele frequencies of these SNPs between
controls and T1DM cases (Table 2). Thus, after all prune
and excluding from 331 SNPs, rs7990 SNPs of HLA-
DQA1 shows a negative association with T1DM. The
pairwise LD values (D’ and r2) among studied SNPs
were provided in Figure 1 and in Table 3. Linkage
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formed 3 haplotype blocks, suggested that haplotype
study might be useful. Haplotype-phenotype association
analysis using SNPs that were located in the LD blocks
in block 1 (rs1047993 and rs707949) showed association
with T1DM (Table 3).
Conclusions
The complex nature of the HLA region on chromosome
6p21.31, with the high LD between genes, has made it
enormously difficult to explicate the effect of individual
genes for the risk of developing T1DM. The studies
suggested that HLA Class II DRB1-DQB1 contribute
to T1DM susceptibility. Calculating for the influence
of class II DR-DQ haplotype and genotype effects, a
role in T1DM has been shown of additional HLA
Class II DPB1[16].
New studies by sequencing has yielded many SNPs
that include thirteen SNPs from class III alleles, which
showed evidence of an effect on T1DM risk, although
some of the SNPs are in tight LD with each other. The
strongest association within class III markers was with
rs2395106 that maps 50 to the NOTCH4 gene and the se-
cond association was with rs707915 mapping to the MSH5
gene, in a block of six markers significantly associated with
T1DM after adjusting for LD with DR-DQ [39].
A widespread SNP analysis of the extended MHC in
237 families with Type 1A from the U.S. and 1,240 fam-
ilies from the T1DGC was conducted and showed an as-
sociation with Type 1A diabetes (rs1233478, p = 1.6 x
10-23), in the UBD/MAS1L region, telomeric of the clas-
sic MHC [40]. Another study from T1DGC on HLA
markers showed 296 significant SNPs in a narrow ge-
nomic region, some of these markers are close to one
another and in strong LD. Therefore, although the SNPs
that stand for independent signals without LD, some
high-LD markers can produce correlated associations in
the study. However, high-LD and long haplotype blocks
will also deter fine mapping precisely. This study also
shows that SNPs with the smallest P values is from the
HLA-DR and -DQ region which confers the major ge-
netic risks for T1DM [41].
Most of these recent studies have used data produced
by the T1DGC and therefore are from Caucasoid popu-
lation, and they conducted the most detailed investiga-
tion of the HLA complex in disease, characterizing over
3,000 SNPs, and independently tested all previously
reported T1DM susceptibility genes [42,43].
In this study we used a sequencing SNP approach to
characterize the polymorphisms in HLA genes. We
carried out sequencing in 151 cases and 151 normal
healthy participants, followed by statistical analysis of
the SNPs. Out of 331 exonic SNPs identified, only 10 is
following HWE. Thus, after all pruning and excludingfrom 331 SNPs, and rs7990 SNP of HLA-DQA1 showed
significant protection from T1DM. Linkage disequilib-
rium analysis revealed 3 haplotype blocks and further
haplotype-phenotype association analysis did show asso-
ciation between haplotypes in block 1 (rs1047993 and
rs707949) and T1DM.
We have also done the study based on alleles and the
findings are similar like the DQA1*0103 allele is a novel
allele with a significant association with the protection
from T1DM in Eastern Indian Bengali population from
India [44]. To our knowledge, this study is the first of a
kind which has tried to check the HLA association with
T1DM by SNPs analysis in India. As said before most of
these recent studies have used data formed by the
T1DGC, and they use refined statistical methods to con-
trol for the complexity of the HLA region because of the
extended LD and polymorphic loci. Still the deviation of
some results suggests the difficulty of examine the inde-
pendent genetic contribution of genes in this region to
the risk of developing T1DM. It is most likely that more
SNPs with individual but smaller or rarer effects on dia-
betes risk can be identified in this region. However, to
find these SNPs new approaches for analyzing genetic
association data are needed. In addition, large numbers
of subjects may help to give more robust and confident
association with T1DM.
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